March 9, 2026
Why this setup matters for banking interviews
If you’re preparing for investment banking recruiting, this is the kind of market backdrop you want to be able to explain cleanly: equity investors are de-risking, credit investors are still willing to fund elite issuers, energy shocks are changing the rate-cut conversation, and strategic buyers are still paying for scale.
That combination gives you several useful interview angles. You can talk about how higher oil prices feed inflation expectations, why that affects Treasury yields and mortgage rates, how investment-grade demand can stay strong even when equities sell off, and why consolidation still makes sense in fragmented or logistics-heavy industries.
The cleanest examples are Amazon’s planned $37 billion to $42 billion bond sale to fund AI infrastructure and Cintas’s $5.5 billion agreement to acquire UniFirst. One is a capital markets story. The other is a strategic M&A story. Together, they show that large companies are still willing to move aggressively when the strategic rationale is obvious.
Equities sold off as investors moved into risk-off mode
Major U.S. indexes finished lower as investors reacted to geopolitical tensions, rising oil prices, and weaker economic data. The S&P 500 fell about 2% for the week, the Dow Jones Industrial Average dropped roughly 3%, and the Nasdaq Composite declined about 1.2%. Small caps were hit harder, with the Russell 2000 down 4.1%, which is usually a good signal that investors are reducing risk appetite.
The pressure wasn’t just a slow drift lower. On one trading day, the S&P 500 fell 1.3%, the Dow dropped 453 points, and the Nasdaq declined 1.6%. That matters because interviewers often want to see whether you can connect market moves to a broader cause-and-effect chain rather than just reciting index performance.
Here, the chain is straightforward. Rising Middle East tensions pushed oil prices higher. Higher energy costs raise inflation concerns and can pressure both corporate margins and consumer spending. At the same time, weaker labor market data and slower growth created more uncertainty around the U.S. economy. The result was a classic risk-off week: investors sold equities and shifted attention toward safer assets.
Amazon’s bond sale is a clean capital markets case study
Amazon announced plans to raise $37 billion to $42 billion through one of the largest corporate bond sales ever by a technology company. The deal includes multiple tranches in U.S. dollars and euros, with maturities ranging from about 2 years to 50 years.
The use of proceeds is the interview-worthy part. Amazon is raising debt to help fund major artificial intelligence infrastructure spending, including data centers and computing capacity. That’s exactly the type of capex story bankers should be able to discuss: a company with strong credit quality uses the bond market to fund long-duration strategic investment instead of relying entirely on cash flow or equity issuance.
Demand was extremely strong. The offering reportedly drew about $126 billion in orders, far above the amount Amazon planned to issue. That tells you investors still have appetite for high-quality investment-grade credit, even in a market where equities are volatile and macro risks are rising.
It also helped drive a record $66 billion of investment-grade bond issuance in a single day. For interviews, don’t just say “Amazon issued debt.” Say the issuance shows how major technology companies are using the debt markets to fund AI investment, and how strong demand for investment-grade paper can coexist with equity-market caution.
Simple interview line: Amazon’s bond sale shows that AI capex is no longer just an equity story. It’s now a major driver of investment-grade debt issuance, and investors are willing to fund it when the issuer has scale and credit quality.
The Fed narrative changed because oil changed
February CPI came in largely as expected. Headline CPI rose 0.3% month over month, putting the 12-month inflation rate at 2.4%. Core CPI, excluding food and energy, rose 0.2% for the month and 2.5% year over year. Both annual rates were unchanged from January.
That sounds stable, but the market is focused on what comes next. Oil briefly moved above $100 per barrel after the U.S.-Israel attack on Iran, and higher energy costs are expected to filter into transportation, shipping, and consumer goods. That complicates the Federal Reserve’s path because inflation was still above the 2% target before the oil shock.
Investors reduced expectations for Fed rate cuts. Markets pushed the likely timing of cuts out to at least next summer after previously expecting multiple cuts as soon as this summer. Short-term Treasury yields rose as financial conditions tightened, and the yield curve flattened as investors reassessed growth and inflation risks.
This is a useful rates answer because it includes both sides of the Fed’s problem. Higher oil prices can lift inflation, but they can also hurt growth by squeezing consumers and businesses. The question becomes whether the Fed looks through the shock as temporary or waits longer to cut because inflation expectations are at risk.
The dollar benefited from safe-haven demand
The U.S. dollar strengthened to a multi-month high as the Iran conflict continued. Investors moved toward the dollar because of geopolitical uncertainty, higher oil prices, and the United States’ relative position as a net energy exporter.
The euro weakened because Europe is more reliant on imported energy. That creates a tougher policy trade-off: weaker growth on one side and higher inflation on the other. If energy disruptions persist, the dollar could remain supported and the euro could stay under pressure. If the conflict ends, safe-haven flows could fade and markets could reprice Fed cuts, which would likely pressure the dollar lower.
That’s a good FX framework for interviews: safe-haven demand, relative energy exposure, and monetary policy expectations all matter at the same time.
LNG may be the bigger commodity stress point
Oil grabbed the headlines, but liquefied natural gas may face an even more difficult disruption if the Strait of Hormuz remains impaired. Roughly 20% of global LNG exports transit the Strait, with most of that supply coming from QatarEnergy’s Ras Laffan complex.
After Iranian drone strikes on March 2, Qatar stopped output entirely, removing nearly a fifth of global LNG supply overnight. The issue is that LNG has fewer workarounds than oil. Oil production is spread across many countries and can sometimes move through alternative routes. LNG requires specialized ships and infrastructure, and operations cannot simply be turned off and back on.
Restarting Ras Laffan could take weeks, and LNG tankers valued at about $250 million each are unlikely to move until operators are confident the Strait is safe. European gas prices surged 63% in the week, the largest weekly gain since Russia invaded Ukraine in 2022. Asian LNG traded at $23.40 per million British thermal units, and some Europe-bound vessels began diverting toward Asia as pricing spreads widened.
For banking interviews, this is a strong supply-chain and commodity-infrastructure point. Not every commodity shock is equal. A disruption in a market with limited storage, specialized transportation, and concentrated supply can have more lasting effects than a more diversified market.
Emerging markets are feeling the dollar and energy squeeze
The Strait of Hormuz disruption also hit emerging markets. Western commercial shipping through the Strait remained effectively halted, while limited traffic connected to Iran or China continued. Vessel-tracking data showed eight commercial transits on March 10 and four more early the next day, although the numbers may be understated because some ships turned off tracking signals and electronic jamming distorted vessel data.
Emerging-market assets came under pressure. The MSCI equity index had its biggest weekly fall in six years, bond yields rose sharply, and the stronger dollar tightened global financial conditions. This is another useful recruiting point: EM stress often comes from a combination of weaker risk sentiment, higher U.S. yields, stronger dollar funding pressure, and commodity exposure.
M&A is still happening where scale creates obvious synergies
Cintas agreed to acquire uniform supplier UniFirst for $5.5 billion in a cash-and-stock transaction. UniFirst shareholders are set to receive $155 in cash plus 0.772 Cintas shares for each UniFirst share, equal to about $310 per share based on Cintas’s March 9 closing price. UniFirst shares rose 7.8% on March 11, while Cintas shares fell 1.4%.
The strategic rationale is straightforward. The combined company will serve about 1.5 million businesses across North America. Cintas expects the deal to increase earnings by the second full year after closing and anticipates about $375 million in operating cost cuts. Cintas generated roughly $10 billion in revenue in its most recent fiscal year, while UniFirst reported about $2.4 billion.
This is a classic strategic-buyer answer: scale, route density, purchasing power, operational efficiencies, and a stronger competitive position. The deal is expected to close in the second half of 2026 and still requires shareholder approval.
There were other deal-related stories too. Ondas is shifting from technology provider toward defense prime contractor through its merger with Mistral, gaining access to U.S. Army and Special Operations contract vehicles. Bill Ackman’s Pershing Square is also seeking $5 billion to $10 billion through a combined offering tied to Pershing Square Inc. and Pershing Square USA, with a $2.8 billion private placement from family offices, pension funds, and insurance companies.
Biotech offers a different kind of interview angle
Vertex Pharmaceuticals is trying to move beyond its cystic fibrosis identity and become a multi-franchise biotech platform. Its kidney drug povetacicept passed a final clinical trial, cutting a key marker of kidney damage by 52%. Shares rose more than 8% on the news, and a Biologics License Application filing for accelerated FDA approval is expected in the first half of 2026.
Vertex also has JOURNAVX, a non-opioid painkiller expected to triple prescriptions in 2026 after securing coverage across major insurers, and CASGEVY, its gene-editing treatment for sickle cell disease. Management guided to at least $500 million in non-cystic fibrosis revenue this year. The investment debate is whether diversification can reduce the valuation discount tied to concentration risk.
CRISPR Therapeutics is another gene-editing name to watch. The stock fell from about $60 to around $40 after a convertible debt offering, but the company has the first approved gene-editing therapy in the U.S., Casgevy, priced at $2.2 million for a one-time sickle cell treatment. Revenue topped $100 million in 2025, patient numbers nearly tripled, and only 300 patients have started treatment out of about 60,000 who qualify.
For interviews, biotech is less about memorizing drug names and more about understanding commercial adoption, reimbursement, pipeline risk, and how financing decisions affect valuation.
What I’d have ready for recruiting conversations
- Capital markets: Amazon’s $37 billion to $42 billion AI bond sale drew about $126 billion in orders, showing strong investment-grade demand despite macro volatility.
- Rates: Stable February CPI was overshadowed by the oil shock, which pushed markets to delay expected Fed cuts.
- Commodities: LNG may be more structurally exposed than oil because supply is concentrated and transportation requires specialized vessels.
- M&A: Cintas buying UniFirst is a clean strategic acquisition built around scale, synergies, and route density.
- Markets: Equities sold off, small caps underperformed, and the dollar strengthened as investors moved into safer assets.
If you can connect those points without sounding rehearsed, you’ll be in good shape. The best answers don’t just describe what happened. They explain who wins, who loses, how financing conditions change, and why a banker would care.